(Q45709943)

15 December 2017

title

Effect of prematurity on respiratory syncytial virus hospital resource use and outcomes (English)

1 reference

15 December 2017

Susan D. Horn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14615712

1 April 2024

Randall J. Smout

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14615712

1 April 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

15 December 2017

https://api.elsevier.com/content/article/PII:S0022347603005092?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1067/S0022-3476(03)00509-2

https://api.elsevier.com/content/article/PII:S0022347603005092?httpAccept=text/plain

1 April 2024

1 reference

https://api.crossref.org/works/10.1067/S0022-3476(03)00509-2

The Journal of Pediatrics

1 April 2024

published in

1 reference

15 December 2017

volume

143

1 reference

15 December 2017

issue

5 Suppl

1 reference

15 December 2017

page(s)

S133-41

1 reference

Standardizing the care of bronchiolitis

15 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1067/S0022-3476(03)00509-2

Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999.

1 April 2024

2

1 reference

https://api.crossref.org/works/10.1067/S0022-3476(03)00509-2

Development of the immune system in very low birth weight (less than 1500 g) premature infants: concentrations of plasma immunoglobulins and patterns of infections

1 April 2024

5

1 reference

https://api.crossref.org/works/10.1067/S0022-3476(03)00509-2

Serum immunoglobulin levels and incidence of infection during the first year of life in full-term and preterm infants

1 April 2024

6

1 reference

https://api.crossref.org/works/10.1067/S0022-3476(03)00509-2

PICNIC (Pediatric Investigators Collaborative Network on Infections in Canada) study of the role of age and respiratory syncytial virus neutralizing antibody on respiratory syncytial virus illness in patients with underlying heart or lung disease

1 April 2024

7

1 reference

https://api.crossref.org/works/10.1067/S0022-3476(03)00509-2

Severity assessment in children hospitalized with bronchiolitis using the pediatric component of the Comprehensive Severity Index

1 April 2024

8

1 reference

https://api.crossref.org/works/10.1067/S0022-3476(03)00509-2

Effect of practice variation on resource utilization in infants hospitalized for viral lower respiratory illness

1 April 2024

9

1 reference

https://api.crossref.org/works/10.1067/S0022-3476(03)00509-2

Development of a pediatric age- and disease-specific severity measure

1 April 2024

11

1 reference

https://api.crossref.org/works/10.1067/S0022-3476(03)00509-2

Lessons from evaluating an automated patient severity index

1 April 2024

12

1 reference

https://api.crossref.org/works/10.1067/S0022-3476(03)00509-2

Results of a collaborative quality improvement program on outcomes and costs in a tertiary critical care unit

1 April 2024

16

1 reference

https://api.crossref.org/works/10.1067/S0022-3476(03)00509-2

A study of the relationship between severity of illness and hospital cost in New Jersey hospitals

1 April 2024

18

1 reference

https://api.crossref.org/works/10.1067/S0022-3476(03)00509-2

Predicting in-hospital survival of myocardial infarction. A comparative study of various severity measures

1 April 2024

20

1 reference

https://api.crossref.org/works/10.1067/S0022-3476(03)00509-2

Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion

1 April 2024

24

1 reference

https://api.crossref.org/works/10.1067/S0022-3476(03)00509-2

Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants

1 April 2024

25

1 reference

https://api.crossref.org/works/10.1067/S0022-3476(03)00509-2

Rates of hospitalization for respiratory syncytial virus infection among children in medicaid

1 April 2024

26

1 reference

https://api.crossref.org/works/10.1067/S0022-3476(03)00509-2

Human lung growth in late gestation and in the neonate

1 April 2024

29

1 reference

https://api.crossref.org/works/10.1067/S0022-3476(03)00509-2

1 April 2024

Identifiers

1 reference

15 December 2017

1 reference